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Original investigation
1)
Introduction
The high prevalence of hypokalemia ranging from 10%
to 36% has been noticeably observed in continuous ambu-
latory peritoneal dialysis (CAPD) patients
1-3), while hyper-
kalemia is more prevalent in hemodialysis (HD) patients
4).
Furthermore, hypokalemic CAPD patients display excess
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mortality, even after adjusting for multiple confounding
factors
5).
Serum potassium (K
+) concentration is determined by
factors influencing both external and internal balance.
Hypokalemia in stable CAPD patients may result from in-
adequate dietary K
+ intake and removal of K
+ via dialy-
sates, intracellular K
+ shift influenced by factors affecting
internal balance (such as insulin, catecholamines, aldoster-
one, and osmolality), or both. Hypokalemia in CAPD pa-
tients is a valid surrogate marker for malnutrition, and se-
rum levels of K
+ and albumin are well correlated, suggest-
ing that poor dietary K
+ intake might derange the external
balance
5, 6). Although unproven, it has also been proposed
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could increase serum K
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+ balance in CAPD patients on icodextrin could be related
to enhanced nutritional status rather than its impact on acute intracellular K
+ redistribution.
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that insulin secretion stimulated by continuous intra-
peritoneal glucose absorption is a contributing factor in
deranged internal K
+ redistribution
7).
Following the introduction of 7.5% icodextrin (ID), a
new class of osmotic agents that is an alternative non-glu-
cose-containing dialysate, the clinical benefits of ID have
been noted to enhance fluid removal and to improve sys-
temic metabolic derangements such as hyperglycemia, hy-
perinsulinemia, and muscle wasting
8). Although many
randomized and observational studies have demonstrated
the numerous clinical benefits of ID compared to conven-
tional glucose-containing dialysate (GD)
9), the impact of
ID on K
+ metabolism has not been evaluated. We evaluated
differences in serum K
+ profiles and influencing factors
related to external or internal K
+ balance between conven-
tional GD and ID in stable CAPD patients.
Subjects and methods
1. Study population
Two hundred ninety-two patients (276 at Severance
Hospital, Yonsei University, Seoul and 16 at Hanyang
University Guri Hospital, Guri, Korea) on CAPD for more
than 6 months were initially included for the retrospective
study from Jan. 2006 to Dec. 2007. Daily dietary intake
of K
+ was not restricted in these patients. Thirty-seven pa-
tients (20 on GD and 17 on ID) were excluded from the
final analysis due to peritonitis (n=11), acute cardio-
vascular events or severe gastrointestinal symptoms (diar-
rhea or vomiting) requiring admission (n=11), death (n=6),
and conversion to either transplantation (n=5) or hemodial-
ysis (n=4). When divided by the type of dialysate used
in the overnight long dwell (8-10 hrs) for the minimum
period of 3 consecutive months, 116 patients were on con-
ventional GD (1.5% or 2.5% or 4.5% Dianeal
®; Baxter
Corporation, Chicago, IL, USA), and the remaining 139
patients were on ID (7.5% glucose-polymer dialysate;
Extraneal
®, Baxter Corporation, Chicago, IL, USA). Also,
to evaluate the differences for ID use, the ID group was
divided to pre-ID (before ID use) and post-ID (after ID
use) groups.
2. Study assessments
Hypokalemia was defined as serum K
+ level was lower
than 3.5 mEq/L. Prevalence of hypokalemia was defined
as frequency of one or more events of hypokalemia during
3 consecutive months, not by mean serum K
+ level. The
blood collections for the biochemical data including serum
K
+ measurement in the 255 CAPD patients with 4 ex-
changes of dialysates per day were mostly performed to-
ward the end of each cycle, when they visited the out-
patient CAPD clinic for a monthly routine check-up. Mean
values of serum level of K
+, albumin, creatinine, and total
CO2 for the last 3 consecutive months in a 2-year ob-
servation period were compared between the two treatment
groups (GD vs ID). The use of medication affecting K
+
balance such as angiotensin-converting enzyme inhibitors
(ACEi) or angiotensin receptor blockers (ARB), beta-
blockers, K
+-sparing diuretics, digoxin, and K
+-supple-
ments for more than 1 month was also analyzed.
Serum levels of K
+, albumin, creatinine, total CO2, cal-
cium, phosphorus, blood urea nitrogen (BUN), weekly
Kt/V, and conventional objective nutritional markers in-
cluding body weight, body mass index (BMI), total choles-
terol, and normalized protein equivalent of total nitrogen
appearance (nPNA) were analyzed before ID (Pre-ID) and
after ID (Post-ID) treatment in the 139 patients on ID.
These parameters were expressed as the mean values of
3 consecutive months on GD just before changing to ID
(Pre-ID), and at the end of observation after changing to
ID (Post-ID) during the 2-year period. Serum albumin was
measured by the bromocresol purple method, and serum
creatinine by the Jaffe method. Weekly Kt/V was de-
termined using standard methods
10). The nPNA was calcu-
lated using the modified Bergstrom formula and normal-
ized by ideal body weight
11).
3. Statistical analysis
SPSS 12.0.1 for Windows software was used for all stat-
istical analyses (SPSS Inc, Chicago, IL, USA). Descriptive
data are expressed as mean±SD (standard deviation).
Comparisons of parameters either between GD and ID or
between Pre-ID and Post-ID periods were performed byJH Yi et al. : Hypokalemia in CAPD Patients 81
independent or paired t-tests, respectively. Frequency of
hypokalemia, among 3 groups, was analyzed by Chi-square
test. Correlations between serum K
+ and other parameters
were evaluated using the Pearson correlation-coefficient.
Simple linear and stepwise multiple linear regression anal-
yses were performed for the factors significantly associated
with serum K
+. A P<0.05 was defined as statistically
significant.
Results
1. Demographic and baseline biochemical data
Most of the demographic features and baseline charac-
teristics were similar between the GD and ID groups, in-
cluding sex (M/F, 58/58 vs 66/73), diabetes (21% vs 23%),
serum albumin (3.6±0.4 g/dL vs 3.6±0.4 g/dL), serum crea-
tinine (11.0±3.8 mg/dL vs 11.7±4.1 mg/dL), and drugs af-
fecting K
+ balance, except for duration of peritoneal dialy-
sis (PD) (85±52 months vs 23±19 months, P<0.05), serum
total CO2 (27.7±2.4 mEq/L vs 28.2±2.5 mEq/L, P<0.05),
intake of ACEi or ARB. Intake of ACEi or ARB (67%
vs 80%, P<0.05) and age (57±13 years vs 54±12 years,
P<0.05) were different between the two groups (Table 1).
2. Serum K
+ profiles
As shown in Fig. 1, the prevalence of hypokalemia was
similar between GD and ID, 16.7% and 17.3%, respec-
tively (P=0.894). However, when the frequency distri-
bution was analyzed in the 139 patients of the ID group
before (Pre-ID) and after ID (Post-ID), the prevalence of
hypokalemia was higher in Pre-ID (20.5%) than Post-ID
(17.3%) without statistical significance (P=0.523). In addi-
tion, the mean serum K
+ level (range, 1.5-7.3 mEq/L) was
higher on ID (4.6±0.7 mEq/L) than on GD (4.4±0.6 mEq/
L; P<0.05), and higher in Post-ID (4.6±0.7 mEq/L) than
in Pre-ID (4.3±0.7 mEq/L; P<0.001).
2. Relationship of serum K
+ to nutritional markers
In the 255 CAPD patients, serum K
+ levels were corre-
lated, using simple linear regression analysis, positively
with serum albumin and creatinine, and inversely with age
and diabetes. Conversely, serum total CO2, ID-use, and
ACEi or ARB use were not correlated with serum K
+
levels. In addition, multiple stepwise linear regression anal-
ysis revealed that serum K
+ levels were correlated with
serum albumin and creatinine (Table 2).
However, when 255 patients were divided into young
group (n=130) and old group (n=125) by median age (56
years old) and when multiple stepwise linear regression
analysis was performed in each group, serum K
+ levels
Table 1. Demographic and Baseline Serum Biochemical
Values of 255 Patients on CAPD Divided according to
Their Dialysate Type on Overnight Long Dwell
GD
(n=116)
ID
(n=139) P
Sex (M, F)
Age (years)
Diabetes (n)
Duration of PD (months)
ACEi or ARB
-blocker β
K
+ sparing diuretics
K
+ supplement
Digoxin
Serum potassium (mEq/L)
Serum albumin (g/dL)
Serum creatinine (mg/dL)
Serum total CO2 (mEq/L)
58, 58
57±13
24 (21%)
85±52
78 (67%)
84 (72%)
1
4
1
4.5±0.6
3.6±0.4
11.0±3.8
27.7±2.4
66, 73
54±12
32 (23%)
23±19
111 (80%)
106 (76%)
1
5
0
4.6±0.7
3.6±0.4
11.7±4.1
28.2±2.5
0.689
0.029
0.219
0.001
0.022
0.483
0.898
0.872
0.883
0.030
0.738
0.252
0.008
Values are expressed as mean±SD (standard deviation) or
number of patients (%). CAPD, continuous ambulatory peri-
toneal dialysis; GD, glucose-containing dialysate; ID, non-
glucose-containing dialysate, icodextrin; PD, peritoneal dialy-
sis; ACEi, angiotensin converting enzyme inhibitor; ARB,
angiotensin receptor antagonist; K
+, potassium.
Fig. 1. The prevalence of hypokalemia between patients treated
with glucose-containing dialysate (GD, n=116) and icodextrin (ID,
n=139), and before (Pre-ID) and after (Post-ID) changing to
icodextrin in 139 patients on icodextrin (ID). GD, glucose-con-
taining dialysate; ID, non-glucose-containing dialysate, icodextrin;
Pre-ID, before icodextrin, i.e. on GD; Post-ID, after icodextrin.82 Electrolyte Blood Press 7:79-86, 2009
were very significantly correlated with ID-use (also, serum
creatinine and albumin) in the young group (Table 3). The
results of the old group were similar to the total group
(Table 2).
In 56 patients from the ID group (n=139), in whose data
were possible to perform the paired t-test, serum albumin
(3.6±0.4 g/dL vs 3.5±0.4 g/dL), serum creatinine (11.6±4.1
mg/dL vs 11.0±4.0 mg/dL), serum total CO2 (27.4±2.6
mEq/L vs 26.5±2.7 mEq/L), body weight (62±9.4 kg vs
61±9.5 kg), and BMI (23.6±3.1 vs 23.2±3.3) were sig-
nificantly higher in the Post-ID than Pre-ID group. Dura-
tion of PD was significantly shorter in Post-ID than Pre-ID
(22±18 months vs 57±52 months, P<0.001). Otherwise, se-
rum calcium (9.3±0.8 mg/dL vs 9.3±0.8 mg/ dL), serum
phosphorus (4.8±1.3 mg/dL vs 5.0±1.5 mg/dL), BUN (55±
16.3 mg/dL vs 57±17.8 mg/dL), weekly Kt/V (2.0±0.3 vs
2.0±0.4), total cholesterol (189±37.3 mg/dL vs 183±39.6
mg/dL), and nPNA (1.0±0.2 g/kg/day vs 1.0±0.2 g/kg/day)
were similar in both Pre-ID and Post-ID groups (Table 4).
Discussion
In the present study, the mean serum K
+ levels were
significantly higher for 3 consecutive months on ID than
on either GD (P<0.05) or Pre-ID (P<0.001) (Table 1, 4).
In addition, the prevalence of hypokalemia in the ID sub-
group decreased from 20.5% on GD to 17.3% after chang-
ing to ID, although the distribution of serum K
+ in CAPD
patients on conventional GD and ID was comparable be-
tween the two groups.
To the best of our knowledge, this study is the first
to analyze the difference in the frequency of serum K
+
distribution in chronic stable CAPD patients on conven-
tional GD versus ID for a long dwell at night time, and
on the potential causes of any identified differences.
Consistent with previous reports, the prevalence of hypo-
kalemia was above 10% in both GD and ID patients
1-3).
However, switching from GD to ID improved serum K
+
profiles and increased the frequency of normokalemia,
Table 2. Correlation between Serum Potassium Levels and Other Parameters in 255 Patients on CAPD Analyzed by Simple
and Multiple Stepwise Linear Regression
Independent Variables
Simple Linear Regression Multiple Linear Regression
β Correlation (r) P β SE ( ) β P
Serum creatinine
Serum albumin
Age
Diabetes
ACEi or ARB use
Icodextrin use
Serum total CO2
0.053
0.357
0.120 –
0.384 –
0.127
0.160
0.017 –
0.357
0.238
0.234
0.240
0.085
0.121
0.066
<0.001
<0.001
<0.001
<0.001
0.179
0.540
0.314
0.037
0.264
0.002 –
0.101 –
0.066
0.139
0.015 –
0.012
0.102
0.004
0.113
0.102
0.085
0.016
0.003
0.010
0.649
0.370
0.521
0.104
0.367
CAPD, continuous ambulatory peritoneal dialysis; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor
antagonist.
Table 3. Correlation between Serum Potassium Levels and Other Parameters in Young Group ( 56 years old) and Old ≤
Group (>56 years old) Analyzed by Multiple Stepwise Linear Regression
Independent Variables
Age 56 (n=130) ≤ Age>56 (n=125)
Multiple Linear Regression Multiple Linear Regression
β SE ( ) β P β SE ( ) β P
Icodextrin use
Serum creatinine
Serum albumin
Diabetes
ACEi or ARB use
Serum total CO2
0.399
0.035
0.317
0.275 –
0.271
0.040 –
0.107
0.160
0.132
0.185
0.145
0.022
<0.001
0.027
0.018
0.138
0.064
0.067
0.127 –
0.044
0.313
0.032
0.006 –
0.002 –
0.131
0.018
0.155
0.146
0.140
0.024
0.333
0.014
0.046
0.826
0.965
0.924
ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor antagonist.JH Yi et al. : Hypokalemia in CAPD Patients 83
which was accompanied by significant improvements in
nutritional status, such as BMI, and biochemical markers
of nutrition such as serum albumin and creatinine (Table
4). In addition, serum K
+ levels were positively associated
with serum albumin and creatinine in the total group and
were significantly associated with ID-use in the young
group (Table 2, 3). Taken together, these results demon-
strate that the improved serum K
+ profiles observed in
young CAPD patients on ID were accompanied by the en-
hancement of some important nutritional markers.
Homeostasis of K
+ can be maintained by the integrated
activities of both transcellular K
+ redistribution or shifting
(internal balance) and dietary intake or external losses
through the gastrointestinal tract, skin, or kidneys (external
balance)
7). In the state of negligible renal K
+ excretion and
a fixed amount of fecal loss in end stage renal disease
patients, the amount of K
+ removed by CAPD is de-
termined by the instillation and ultrafiltration volumes as
well as the type of dialysate, the number of daily ex-
changes, and the serum K
+ level of the patient. Under oth-
erwise stable medical conditions in CAPD patients with
four daily exchanges of conventional GD, K
+ removal via
dialysis equals about 25-30 mEq of K
+ per day, which is
significantly lower than the 60-90 mEq of usual daily K
+
intake on the western diet
1, 12). Most CAPD patients have
normokalemia, but some are still prone to develop hypo-
kalemia
1, 4).
In stable CAPD patients without excessive stool losses,
hypokalemia presumably develops due to either decreased
dietary K
+ intake or increased dialysis adequacy. Raising
peritoneal dialysis adequacy targets to Kt/V per week >
2.0 leads to a rise in the frequency of hypokalemia and
a greater number of CAPD patients requiring K
+ supple-
mentation
12). In this study, however, weekly Kt/V was
equal before (Pre-ID) and after ID (Post-ID), in spite of
a significantly higher prevalence of hypokalemia in the pe-
riod on GD before changing to ID (Pre-ID). This finding
suggests that the adequacy of dialysis may be irrelevant
in influencing the prevalence of hypokalemia.
A different balance study in a small group of four CAPD
patients with hypokalemia who required persistent K
+ sup-
plements revealed positive external K
+ balances
7). The
amount of K
+ in dietary K
+ intake and oral supplements
minus the amount removed by urine and dialysate was
positive. The authors suggested, as a possible hypothesis
for hypokalemia in CAPD patients, that the internal K
+
balance was broken (i.e., K
+ redistribution into the intra-
cellular compartment) by the excessive release of insulin
with continuous glucose absorption through the peritoneal
membrane
7). In reality, the K
+ content in muscles of CAPD
patients is elevated, indicating that K
+ stores are well main-
tained in the intracellular compartment by the intracellular
shift of K
+ promoted by a higher insulin level in response
to peritoneal glucose absorption, despite continuous re-
moval of K
+ on CAPD
7, 13). However, in our previous bal-
anced study of acute intraperitoneal K
+ load in nine stable
CAPD patients on conventional GD or ID, we observed
that the plasma [K
+] increment was significantly high in
ID compared to GD after K
+ load and the increment of
insulin was significantly lower in ID than in GD
14). Thus
glucose containing dialysate could induce insulin secretion
that caused K
+ redistribution toward intracellular space
14).
Although we only evaluated nine CAPD patients, the result
of seven diabetic PD patients in our study has shown that
Table 4. Comparison between Serum Biochemical Data,
Nutritional Markers, and Weekly Kt/V before (Pre-ID) and
after (Post-ID) Changing to Icodextrin in 56 Patients in the
ID Group
Pre-ID Post-ID
Duration (month)
Serum potassium (mEq/L)
Serum albumin (g/dL)
Serum creatinine (mg/dL)
Serum total CO2 (mEq/L)
Serum calcium (mg/dL)
Serum phosphorus (mg/dL)
BUN (mg/dL)
Weekly Kt/V
Body weight (kg)
BMI (kg/m
2)
Total cholesterol (mg/dL)
nPNA (g/kg/day)
57±52
4.3±0.7
3.5±0.4
11.0±4.0
26.5±2.7
9.3±0.8
4.8±1.3
55±16.3
2.0±0.3
61±9.5
23.2±3.3
189±37.3
1.0±0.2
22±18
†
4.6±0.7
†
3.6±0.4
†
11.6±4.1
†
27.4±2.6
†
9.3±0.8
5.0±1.5
57±17.8
2.0±0.4
62±9.4*
23.6±3.1*
183±39.6
1.0±0.2
Values are expressed as mean±SD (standard deviation). Pre-
ID, before icodextrin, i.e. on glucose-containing dialysate;
Post-ID, after icodextrin; BUN, blood urea nitrogen; BMI,
body mass index; nPNA, normalized protein equivalent of
total nitrogen appearance.
*P<0.05 vs Pre-ID.84 Electrolyte Blood Press 7:79-86, 2009
the increment of insulin was significantly high in GD com-
pared to ID, after K
+ load
14). Such results represented that
insulin, also in diabetic end-stage renal disease (ESRD)
patients, could play a role in controlling internal K
+ bal-
ance
14).
Hypokalemia, a somewhat frequent disorder in patients
on chronic CAPD in this study, seemed to be related to
low dietary K
+ intake for an extended period, making mal-
nutrition an important contributing or associated factor.
Recent reports have shown that hypokalemia on CAPD is
associated with nutritional indicators such as serum albu-
min level, PNA, and BMI
6). Furthermore, serum K
+ levels
in Chinese CAPD patients are associated with nutritional
status and severity of comorbid conditions
5). The hypo-
kalemia seems to most likely be a surrogate marker of mal-
nutrition combined with poor dietary intake of K
+. The
high prevalence of hypokalemia in CAPD patients, which
is consistent with the high prevalence of malnutrition in
CAPD patients on conventional GD, has been noted as
18-56% in numerous previous reports
15, 16).
When hypokalemic pediatric CAPD patients increase
their dietary K
+ intake by a small amount (11-64%) without
any other K
+ supplementation, serum K
+ levels return to
the normal range, suggesting that hypokalemia may be cor-
rectable through dietary counseling to increase K
+ intake
17).
Even so, the chronic management of hypokalemia in stable
CAPD patients may require improvement of nutritional sta-
tus on a long-term basis rather than simple correction by
K
+ supplementation on a short-term basis through either
oral routes, such as a K
+-rich diet and oral K
+ preparation,
or intraperitoneal routes
3, 17). Increased dietary protein in-
take with multidisciplinary intervention represents an ap-
propriate approach for chronic management of hypo-
kalemia in CAPD patients with malnutrition, since dietary
protein contains about 1 mEq of K
+ per gram
18). In our
analysis, however, nPNA (a known indicator of dietary
protein intake) was similar between the Post-ID (on ID)
and the Pre-ID (on GD) periods, despite higher Post-ID
serum K
+ levels. The reliability of nPNA as an indicator
has been questioned, particularly in hypercatabolic cases
with malnutrition
19).
ID, a non-glucose-containing polymer-based PD sol-
ution, was originally produced to treat ultrafiltration fail-
ure, particularly that caused by rapid glucose absorption
due to the high transport type of peritoneal membranes
in CAPD patients
20). ID has been widely used for single
nighttime long dwells, resulting in better fluid status and
blood pressure control in CAPD patients with high peri-
toneal membrane permeability (because of the increase in
ultrafiltration volume), enhanced quality of life and patient
survival
21), and biochemical benefits including improved
lipid profiles and insulin sensitivity
22, 23).
Short-term treatment with ID for 1 week is associated
with a greater loss of amino acids from dialysate, thus,
long term treatment with ID could have a detrimental effect
on nutritional status. The greater loss of amino acids might
merely reflect the extra loss of amino acids during a day-
time dwell. In reality, plasma levels of amino acids do
not change, indicating a lower probability of nutritional
deficits on ID
24). Furthermore, in view of the proportion-
ately greater muscle wasting and increased fat accumu-
lation in CAPD patients maintained on PD regimens with
a higher exposure to glucose, those with lower glucose
exposure and sustained use of ID for daily long dwells
might experience beneficial effects on their nutritional
status.
We observed that ID improved some nutritional markers
compared to conventional GD in CAPD patients, which
were associated with better serum K
+ profiles. There are
a number of possible explanations for these benefits of ID.
First, the increase of serum K
+ levels seen with ID could
be related to improved volume status, as supported by the
observation that serum K
+ levels are positively correlated
with ultrafiltration volume in peritoneal equilibration
tests
6). Second, hypokalemia in CAPD patients has been
proposed as a surrogate marker for malnutrition or severe
underlying comorbid conditions, which are both related to
poor dietary K
+ intake
5). Third, the hyperglycemia and de-
layed gastric emptying with reduced gastrointestinal mo-
tility seen in conventional GD is improved by the avoid-
ance of glucose in ID, which could lead to improved nutri-
tional status and a higher dietary K
+ intake
25, 26). Finally,JH Yi et al. : Hypokalemia in CAPD Patients 85
ID does not affect appetite, while anorexia is frequently
seen in CAPD patients on conventional GD
27).
This study was limited by its retrospective and cross-
sectional design. The impact of the effluent dialysate of
ID on the nighttime long dwell on the amount of K
+ re-
moved was not considered on a long-term basis and also,
the data of residual renal function and peritoneal function
were not considered for analysis. Moreover, only limited
data from 3 consecutive months in CAPD patients were
included in this study and multivariable analyses of nutri-
tional markers for ID-use were not performed due to small
sample size. In addition, a detailed dietary assessment was
not available in this study. Finally, although serum albumin
was measured in this study, other common nutrition param-
eters, such as assessment of intake and subjective global
assessment (SGA), and anthropometric assessments, such
as skin fold thickness and mid-arm muscle circumference,
were not evaluated
28).
In conclusion, the increase in serum K
+ level after
switching from GD to ID, and the higher levels of serum
K
+ while on ID versus GD, indicate that ID represents a
viable option for managing chronically hypokalemic pa-
tients on CAPD. Serum K
+ was positively correlated with
nutritional factors such as serum albumin level in all pa-
tients and in the ID group, implying that poor nutrition
and K
+ intake might contribute significantly to hypo-
kalemia in CAPD patients.
References
1) Oreopoulos DG, Khanna R, Williams P, Vas SI: Continuous
ambulatory peritoneal dialysis - 1981. Nephron 30:293-303,
1982
2) Khan AN, Bernardini J, Johnston JR, Piraino B: Hypokale-
mia in peritoneal dialysis patients. Perit Dial Int 16:652,
1996
3) Spital A, Sterns RH: Potassium supplementation via the di-
alysate in continuous ambulatory peritoneal dialysis. Am J
Kidney Dis 6:173-176, 1985
4) Tzamaloukas AH, Avasthi PS: Temporal profile of serum
potassium concentration in nondiabetic and diabetic out-
patients on chronic dialysis. Am J Nephrol 7:101-109, 1987
5) Szeto CC, Chow KM, Kwan BC, et al.: Hypokalemia in
Chinese peritoneal dialysis patients: prevalence and prog-
nostic implication. Am J Kidney Dis 46:128-135, 2005
6) Kim HW, Chang JH, Park SY, et al.: Factors associated
with hypokalemia in continuous ambulatory peritoneal dial-
ysis patients. Electrolyte Blood Press 5:102-110, 2007
7) Tziviskou E, Musso C, Bellizzi V, et al.: Prevalence and
pathogenesis of hypokalemia in patients on chronic peri-
toneal dialysis: one center's experience and review of the
literature. Int Urol Nephrol 35:429-434, 2003
8) McIntyre CW: Update on peritoneal dialysis solutions.
Kidney Int 71:486-490, 2007
9) Davies SJ: Exploring new evidence of the clinical benefits
of icodextrin solutions. Nephrol Dial Transplant 21(Suppl
2):S47-50, 2006
10) Nolph KD, Moore HL, Twardowski ZJ, et al.: Cross-sec-
tional assessment of weekly urea and creatinine clearances
in patients on continuous ambulatory peritoneal dialysis.
ASAIO J 38:M139-142, 1992
11) Bergstrom J, Heimburger O, Lindholm B: Calculation of
the protein equivalent of total nitrogen appearance from urea
appearance. Which formulas should be used? Perit Dial Int
18:467-473, 1998
12) Newman LN, Weiss MF, Berger J, Priester A, Negrea LA,
Cacho CP: The law of unintended consequences in action:
increase in incidence of hypokalemia with improved ad-
equacy of dialysis. Adv Perit Dial 16:134-137, 2000
13) Bergstrom J, Alvestrand A, Furst P, Hultman E, Widstam-
Attorps U: Muscle intracellular electrolytes in patients with
chronic uremia. Kidney Int 24(Suppl 16):S153-160, 1983
14) Yi JH, Park JI, Choi HY, Lee HY, Han SW, Kim HJ:
Comparison of icodextrin and 2.5% glucose in potassium
metabolism by acute K
+ load via dialysate in continuous
ambulatory peritoneal dialysis patients. Electrolyte Blood
Press 7:25-30, 2009
15) Kang DH, Kang EW, Choi SR, Yoon SY, Han DS:
Nutritional problems of Asian peritoneal dialysis patients.
Perit Dial Int 23(Suppl 2):S58-64, 2003
16) Young GA, Kopple JD, Lindholm B, et al.: Nutritional as-
sessment of continuous ambulatory peritoneal dialysis pa-
tients: an international study. Am J Kidney Dis 17:462-471,
1991
17) Factor KF: Potassium management in pediatric peritoneal
dialysis patients: can a diet with increased potassium main-
tain a normal serum potassium without a potassium supple-
ment? Adv Perit Dial 23:167-169, 2007
18) Messa P, Mioni G, Maio GD, et al.: Derangement of
acid-base balance in uremia and under hemodialysis. J
Nephrol 14(Suppl 4):S12-21, 2001
19) Harty JC, Boulton H, Curwell J, et al.: The normalized pro-
tein catabolic rate is a flawed marker of nutrition in CAPD
patients. Kidney Int 45:103-109, 1994
20) Peers E, Gokal R: Icodextrin: overview of clinical ex-
perience. Perit Dial Int 17:22-26, 1997
21) Kuriyama R, Tranaeus A, Ikegami T: Icodextrin reduces
mortality and the drop-out rate in Japanese peritoneal dialy-
sis patients. Adv Perit Dial 22:108-110, 2006
22) Bredie SJ, Bosch FH, Demacker PN, Stalenhoef AF, van
Leusen R: Effects of peritoneal dialysis with an overnight86 Electrolyte Blood Press 7:79-86, 2009
icodextrin dwell on parameters of glucose and lipid me-
tabolism. Perit Dial Int 21:275-281, 2001
23) Gursu EM, Ozdemir A, Yalinbas B, et al.: The effect of
icodextrin and glucose-containing solutions on insulin re-
sistance in CAPD patients. Clin Nephrol 66:263-268, 2006
24) van Hoeck KJ, Rusthoven E, Vermeylen L, et al.: Nutritio-
nal effects of increasing dialysis dose by adding an icodex-
trin daytime dwell to Nocturnal Intermittent Peritoneal
Dialysis (NIPD) in children. Nephrol Dial Transplant 18:
1383-1387, 2003
25) Marshall J, Jennings P, Scott A, Fluck RJ, McIntyre CW:
Glycemic control in diabetic CAPD patients assessed by
continuous glucose monitoring system (CGMS). Kidney Int
64:1480-1486, 2003
26) Van V, Schoonjans RS, Struijk DG, et al.: Influence of dial-
ysate on gastric emptying time in peritoneal dialysis pa-
tients. Perit Dial Int 22:32-38, 2002
27) Zheng ZH, Sederholm F, Anderstam B, et al.: Acute effects
of peritoneal dialysis solutions on appetite in non-uremic
rats. Kidney Int 60:2392-2398, 2001
28) Steinman TI: Serum albumin: its significance in patients
with ESRD. Semin Dial 13:404-408, 2000